Earnings results for Aurora Cannabis (NYSE:ACB)
Aurora Cannabis Inc. is estimated to report earnings on 09/09/2020. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 5 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.27. The reported EPS for the same quarter last year was $0.
Analyst Opinion on Aurora Cannabis (NYSE:ACB)
17 Wall Street analysts have issued ratings and price targets for Aurora Cannabis in the last 12 months. Their average twelve-month price target is $18.37, predicting that the stock has a possible upside of 144.24%. The high price target for ACB is $30.00 and the low price target for ACB is $9.00. There are currently 4 sell ratings, 11 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of “Hold.”
Aurora Cannabis has received a consensus rating of Hold. The company’s average rating score is 1.88, and is based on 2 buy ratings, 11 hold ratings, and 4 sell ratings. According to analysts’ consensus price target of $18.37, Aurora Cannabis has a forecasted upside of 144.2% from its current price of $7.52. Aurora Cannabis has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.
Dividend Strength: Aurora Cannabis (NYSE:ACB)
Aurora Cannabis does not currently pay a dividend. Aurora Cannabis does not have a long track record of dividend growth.
Insiders buying/selling: Aurora Cannabis (NYSE:ACB)
In the past three months, Aurora Cannabis insiders have not sold or bought any company stock. Only 11.49% of the stock of Aurora Cannabis is held by institutions.
Earnings and Valuation of Aurora Cannabis (NYSE:ACB
Earnings for Aurora Cannabis are expected to grow in the coming year, from ($10.11) to ($0.85) per share. The P/E ratio of Aurora Cannabis is -0.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Aurora Cannabis is -0.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Aurora Cannabis has a P/B Ratio of 0.19. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.
More latest stories: here